Diabetes Technology Starts: Lukas Schuster from Syntactiq on an AI Diabetes Data Platform for Research

In this episode in our Diabetes Technology Starts series, Lucas Schuster, founder and CEO of Syntactiq, unpacks the gap between what diabetes technology can measure and what research teams can realistically use day to day. We talk about collecting richer contextual data, enabling donation for research, and supporting partners who need to analyze their own sensitive health data, from continuous glucose monitoring logs to EHR datasets, omics data, and clinical trial data.